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The nature  of cellular interactions involved in the  expression of suppressor 
cell  activity  is  a  central  question  in  immunoregulation.  The  effector cell  of 
suppression  in the in vitro plaque-forming cell (PFC) 1 response of naive spleen 
cells to sheep erythrocytes (SRBC) has been identified as an Lyl-,2  ÷ I-J- cell that 
can directly suppress spleen cell cultures depleted of Ly2  ÷ cells (1). It has been 
previously reported  that  suppressor  effector cells  require  an  induction  signal 
from an Ly 1  +, 2- I-J  ÷ cell to express optimal suppressor activity (2). The biological 
activity of both these cells can be replaced by cell free products secreted by these 
cells.  Both  the  Lyl+-derived suppressor  inducer  factor and  Ly2+-derived sup- 
pressor-effector factor require two separate macromolecules: one that is antigen 
binding,  and  one that  is  I-J  ÷ for functional activity (3,  4).  A  number of other 
investigators also report similar antigen-specific suppressor factors composed of 
two separate molecules (5, 6). 
We have extensively studied an antigen-specific suppressor factor (TNP-TsF) 
that can inhibit the adoptive transfer of contact sensitivity to the picryl chloride 
(PCI; 7-9). The biological activity of this factor also requires the interaction of 
two separate  macromolecules.  The  first is an  antigen-binding  l-J-  product se- 
creted by an Lyl+,2  -  I-J- cell that was previously activated by painting the flank 
skin of donor mice with  PCI  (PC1-F).  The second, an antigen  nonbinding  I-J- 
macromolecule secreted by a cell that expresses the same phenotype as suppressor 
effector cells  (Lyl-2  ÷,  I-J-),  is  obtained  from spleen  and  lymph  node cells  of 
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mice immunized with 2,4,6-trinitrobenzene sulfonic acid (TNBSA-F). The pres- 
ence of both these molecules is prerequisite for suppressive activity to be manifest 
(9). 
While these  two molecules work in  tandem to effect suppression,  the exact 
mechanism by which they interact at a  functional level is still unknown. In the 
present set of experiments, we investigated the nature of TNP:TsF activity while 
at the same time unifying elements from two distinct suppressor cell systems. In 
the results described here,  we found that the suppressive activity of TNP-TsF 
required the presence of Ly-2 I-J  + cells in the assay population, and this require- 
ment could be overcome by the addition of either an  Lyl  I-J  + T  cell product 
obtained from animals hyperimmunized to SRBC, or an Ly2 I-J  + T  cell product 
induced  in  an  intermediate  culture  system by  PCI-F  and  TNP-labeled  spleen 
cells. These I-J  + molecules interact only with TNBSA-F, the subfactor of TNP- 
TsF generated from Ly2 cells, to form an antigen nonspecific suppressor factor 
that inhibited the adoptive transfer of contact sensitivity and the anti-SRBC PFC 
response of primed T  cells in vitro. 
Materials and Methods 
Mice 
CBA/J mice (6-8-wk  old males)  were obtained from The Jackson Laboratory (Bar 
Harbor, ME) and rested for 1 wk after arrival at the Yale University School of Medicine 
before use. 
Antigens 
Sheep erythrocytes (SRBC)  were obtained from Colorado Serum  Co.  Denver,  CO. 
Trinitrobenzene sulphonic acid (TNBSA) was obtained from Eastman Organic Chemicals 
(Rochester,  NY),  Picryl  chloride  (PCI)  from Chemotronix (Swannonoa,  NC),  and  4- 
ethoxymethylene-2-phenyloxazolone  (oxazolone, OX) from British Drug House (Gallard- 
Schlesinger Chemical Mfg. Corp., Carle Place, NY). 
Antisera 
Monoclonal anti-Ly sera were generously supplied by F.-W.  Shen,  Memorial Sloan- 
Kettering Cancer Center, New York, NY. Monocional anti-Thy-1 reagents were gener- 
ously provided by Dr. Jonathan Sprent,  University of Pennsylvania, Philadelphia, PA. 
Anti-I-J  K  serum was prepared by hyperimmunizing B 10.A (3R) recipients with a mixture 
of B10.A (SR), spleen, and lymph node cells (antiserum ASM-18) (we thank D. Murphy 
for preparing this antiserum).  1  B3 is a  monoclonal antibody that was produced in this 
laboratory by immunization of normal rats with TNP-TsF. This antibody was found to 
specifically react with the TNBSA-F portion of TNP-TsF (Ptak, manuscript in prepara- 
tion). Depletion of cells bearing Lyt (or Thy-1) markers was achieved by incubating 1 x 
107 cells/ml of antibody appropriately diluted in balanced salt solution (BSS), washing, 
and incubating with complement for 45 min at 37°C. Complement used in these experi- 
ments was serum from rabbits (guinea pigs) selected for low natural cytotoxicity to mouse 
cells. 
Production of Factors 
TNP- and OX-specific T suppressor factors and subfactors were generated as previously 
described (9). A brief description of the procedure used to generate each factor is given 
as follows. 
TNBSA-F.  Mice were injected intravenously with 0.35 ml of a  1% solution of TNBSA 
in distilled water (adjusted to pH 7.2 with sodium hydroxide) on days 0 and 4. 3 d later 
single-cell  suspensions  were  prepared  from  spleen  and  peripheral  lymph  nodes  and 1824  MECHANISMS OF  SUPPRESSION 
cultured in vitro at a  cell density of 1.5  x  107 cells/ml for 48 h  at 37°C in serum-free 
RPMI 1640 medium supplemented with glutamine and antibiotics (culture medium). Cells 
were removed by centrifugation and supernatants were stored at -70°C. 
PCl-F.  Mice were painted with 0.15 ml of a 5% solution of PCI in an ethanol/acetone 
mixture (3:1  vol/vol) in all four paws and the skin of the clipped abdomen. Spleen and 
LN cells of these mice were taken on day 4 and incubated as described above. 
OX-Th-F.  An oxazoione equivalent to TNBSA-F (OX-Th-F) was prepared by injecting 
mice intravenously with 7 x  107 mouse thymocytes to which oxazolone had been conju- 
gated on days 0 and 4, after which spleen cells were harvested on day 7, and cultured in 
the same fashion as were mice that made TNBSA-F. 
TNP-TsF.  Was prepared by intravenous injection of TNBSA solution on days 0 and 
4, followed by skin painting with PCI on day 6. Cultures of spleen and lymph node cells 
were set up on day 8. 
OX-TsF.  Was prepared by intravenous injection of OX-labeled thymocytes (7 x  107/ 
mouse) on day 0 skin painting with oxazolone on day 7, followed on day 9 by culturing 
spleen and lymph node cells for 48 h as described for TNBSA-F. 
LylTsiF.  Preparation of LylTsiF specific for SRBC has been previously described (7). 
Briefly, a suspension of spleen cells from mice hyperimmunized to SRBC were treated 
with anti-Ly2 antibody and rabbit complement, and subsequently cultured in vitro for 48 
h in culture medium supplemented with 10% fetal calf serum (FCS) at a concentration of 
107 cells/ml. After culture, supernatant fluids were cleared and passed through a Millipore 
filter (Millipore/Continental Water Systems, Bedford, MA). 
In Vitro Induction  oil-J + Subfactor by PCI-F 
CBA/J mice were skin sensitized with OX as previously described and 4 d later, single 
cell suspensions of spleen and  LN cells were prepared.  Lymphoid cells (3  ×  108) were 
incubated with  15  ml of undiluted  PCI-F for  1 h  at 37°C,  washed, and then added to 
TNP-labeled normal spleen cells (108) and subsequently incubated for 3 h at 37°C in 5 
ml  of RPMI  1640  medium  supplemented  with  glutamine,  antibiotics,  and  2%  FCS. 
Depletion of cells bearing Ly or I-J markers was accomplished by treating the cells with 
antibody and complement before the addition of PCI-F. Supernatants were then cleared 
and either used directly, or concentrated approximately fivefold with polyethylene glycol 
(tool wt 20,000,  Sigma Chemical  Co.,  St.  Louis,  MO) and  applied to immunosorbent 
columns. 
Absorption of Soluble Factors 
Absorbtion of LylTsiF with erythrocytes was done by mixing  1 ml of culture super- 
natants  with  0.1  ml  of a  50%  suspension  of sheep erythrocytes for  1  h  on  ice.  The 
erythrocytes were removed by centrifugation. TNBSA-F was purified by passage over a 
1  B3 column prepared by conjugation of the monoclonal antibody to cyanogen-bromide- 
activated Sepharose 4B. Purified TNBSA-F was then attached to CNBr-activated Sepha- 
rose 4B. For absorbtion of factors over anti-I-J or TNBSA-F immunosorbents, supernatant 
was passed over relevant Sepharose column, washed extensively, then eluted with 0.2 M 
sodium carbonate, pH 11.0. Filtrate and eluate were then concentrated to original volume 
and dialyzed against first PBS, and then RPMI 1640. 
Adoptive  Transfer of Contact Sensitivity (CS) 
Mice were skin sensitized by application of 0.15 ml of a 5% picryl chloride solution or 
a  3%  oxazolone  solution  to  the  skin  of shaved  abdomen  and  four  paws.  4  d  after 
sensitization single cell suspensions of spleen and LN cells were prepared and then treated 
with anti-Ly-2.1  antibody and complement where noted.  Cells were then incubated in 
the appropriate factors for 1 h at 37°C before being injected into naive recipients (5-6 x 
107 cells/mouse). If mixtures of factors were used, factors were preincubated for 1 h at 
37 °C before being added to to cells.  Recipients were then immediately challenged on the 
ears with the appropriate antigen (0.8% PCI or OX in olive oil). CS responses are expressed 
as  the  increment  of ear  thickness  from  duplicate  measurements (using  an  engineer's PTAK ET AL.  1825 
micrometer (Mitotope) prior to challenge and 24 h later. The increment in ear thickness 
is expressed as mean + SD in units of 10  "3 cm. Values given are the average and the SEM 
for five individual samples from each group. These results are given as typical results 
from three independent experiments. Percent response was calculated according to the 
formula: 
(experimental-negative control)/(positive control-negative control) x  100 (reference 13) 
Statistical analysis was performed on these numbers using a Student's t test comparing the 
suppressed values to the control nontreated sample. 
In Vitro Anti-SRBC Response 
Anti-SRBC responses from immune mice were generated in vitro using a modification 
(13) of a cell culture technique described initially by Mishell  and Dutton (14). Briefly, 
naive CBA/J mice were immunized with 0.2 ml of a  1% (vol/vol) solution of SRBC-BSS 
intraperitoneally. 10 d later, spleens were removed and T  cells were prepared by adding 
spleen  cells  to  plastic  petri  dishes  coated  with  goat  anti-mouse  immunoglobulin  and 
harvesting the nonadherent fraction (14). This procedure removed 95% of the Ig  + cells 
as determined by fluorescence. Thy-1-depleted spleen cells (B cells) were prepared from 
unprimed spleen cells by treating the cells with monoclonal anti-Thy-1 and complement. 
All cells were suspended in culture medium consisting of RPMI 1640 supplemented with 
antibiotics, 10% FCS, 100 mM glutamine, 25 mM Hepes, and 5 x  10  -s M 2-mercaptoeth- 
anol, at a final concentration of 2 x  106 immune T  cells, and 2 x  108 B cells in 1 ml. To 
each culture 0.05 ml of a  1% SRBC suspension was added and cultures were maintained 
in Falcon 3008 plates (Falcon Labware, Div. Becton, Dickinson & Co, Oxnard, CA) for 5 
d in a 5% COs, 95% air incubator at 37 °C. The number of PFC was determined by using 
the Cunningham modification of the Jerne-Nordin plaque assay (16). 
Results 
T  Suppressor  Factors  that  Suppress  in  Adoptive  Transfer  Hapten-specific  CS  Are 
Antigen-specific  and  Composed to  Two Distinct  Subfactors.  CS  to the  haptens  PCI 
and OX can be passively transfered by immune spleen cells into naive recipients. 
The results in  Table I  show that  TNP-TsF can significantly inhibit the passive 
transfer of CS to PCI, while the same factor has little effect on the CS reaction 
of immune  cells to OX.  The converse is also true.  OX-TsF could only inhibit 
the CS of OX-immunized  cells while not affecting the ability to transfer CS to 
PCI. Group 3 shows that complete suppression of CS to PCI can be seen by the 
mixture of two subfactors obtained from cultures of PCl-immune and TNBSA- 
immune cells. Supernatants from cell cultures in which only PCI-immune (PCI- 
F) or TNBSA-immune  (TNBSA-F) cells were present  contained no biological 
activity (groups 4 and 5). 
Inability  of TsF to Suppress  the Passive Transfer of CS in Cells Depleted of Ly2 Cells 
Can Be Overcome by Addition  of I-J  + Chain from SRBC-specific  T  Cell Factor.  We 
investigated  the  cellular  requirements  for TsF  suppressive  activity (Table  II). 
While removal of Ly2  + cells from the immune population did not abrogate their 
ability to transfer CS,  there  was  a  marked  difference in  the  ability of TsF  to 
suppress  this  transfer.  Under  these  conditions,  neither  TNP-TsF  or  OX-TsF 
could alter the transfer of CS to their respective antigens.  Likewise, incubation 
of Ly2 cell-depleted PCl-immune cells with a  mixture of subfactors that yield a 
complete  TNP-TsF  (TNBSA-  and  PCI-F)  had  little  affect on  their  ability  to 
transfer CS,  as did an  I-J  + material  from a  SRBC-specific Lyl  T,iF.  However, 
whole TsF, or the TsF made up of subfactors, supplemented with Lyl TsiF I-J  + 1826  MECHANISMS  OF  SUPPRESSION 
TABLE  I 
T Cell Factors That Suppress the Passive Transfer of Contact Sensitivity Are Antigen Spec~c 
Cells im-  Source  of TsF  incubated  CS  response  in  %  Control  re- 
Group  munized  with immune cells*  adoptive  recipi-  sponse  Suppression 
with  ents  I 
1  PCI  --  8.2 ±  1.23  Standard  Standard 
2  PCI  TNP-TsF  3.0 ±  0.54  36  +  (p <  0.01)  ~ 
3  PCI  PCI-F* +  TNBSA-F  0  3.7 +  0.81  45  +  (p <  0.01) 
4  PCI  PCI-F*  8.1  ±  0.76  98  -- 
5  PCI  TNBSA-F  8.4 ±  0.90  >100  -- 
6  PCI  OX-TsF  8.0 ±  0~74  97  -- 
7  OX  --  9.4 ±  1.08  Standard  Standard 
8  OX  TNP-TsF  8.9 ±  1.17  94  -- 
9  OX  OX-TsF  3.8±0.71  40  +  (p<0.01) 
* Lymphoid  cells  from  mice  immunized  with  either  PCI  or  OX  4  d  earlier  were  mixed  with 
supernatant from  mice immunized to produce  TNP- of OX-TsF.  Immune cells were  incubated 
with TsF for  1 h, then 6  x  107 cells were injected into normal recipients. 
The  48-h supernatant from cultures of cells-from mice whose skins were painted with  PCI  24 h 
before culture. 
0 The  48-h supernatants from cultures of cells from  mice injected  intravenously with  TNBSA on 
days 0  and 4  before  harvesting for culture on day 8.  Immune cells were  incubated with a  50:50 
mix of PC|-F and TNBSA-F. 
124-h  increase  in  ear  swelling  (measured  in  units  of  10-3  cm)  after  painting  with  the specific 
contactant was measured. The nonspecific swelling (that of mice that did not receive immune cells) 
is subtracted, so the resultsare presented as net increase in swelling, +  SD. 
p  value determined using a  Student's t test. 
TABLE  II 
The Requirement of Ly2 Cells in the Passive Transfer of TsF Activity Can Be Overcome by the 
Addition of an I-J +  Molecule Isolated From an SRBC-specific Lyl T Suppressor Factor 
Cells  CS response in 
Group  immu-  Source of factor incubated  adoptive recip-  % Control  Suppression 
nized  with Lyl  immune ceils*  ients*  response 
with: 
1  PCI  None  7.8 +  1.46  Standard  Standard 
2  PCI  TNP-TsF  7.7 ___ 1,10  99  -- 
3  PCI  PCIF  0 +  TNBSA-F m  8.1  +  1,24  >100  -- 
4  PC1  I-J  k  7.6 ±  1.33  98  -- 
5  PCl  TNP-TsF +  I-J k  2.1±0.67  27  +  (p<0.01) 
6  PCl  (PCI-F +  TNBSA-F) +  I-J k  2.4±  1.16  31  +  (p <  0,01) 
7  ox  None  7.2 ±  0.61  Standard  Standard 
8  OX  OX-TsF  8.2 ±  0.64  >100  -- 
10  OX  OX-TsF +  I-J K  3.1  ±  0.87  36  +  (p <  0.01) 
* Immune  cells depleted of Ly2 cells were treated with the appropriate TsF as described in footnote 
.  k  • Table  I.  The  I-J  molecule was obtained  from a  48-h culture supernatant of SRBC-immune 
spleen cells depleted of Ly2 cells by absorption of the supernatant with an anti-I-J  k immunosorbent 
as detailed in materials and methods. I-J  ~ material was added at a  final concentration of 50%. 
* See footnote I, Table I. 
See footnote *, Table I. 
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material significantly reduced the ability of immune Lyl cells to transfer the CS 
reaction. 
Two important points should be noted here: (a) both TNP-TsF and the mixture 
of TNBSA-F and PCI-F require the presence of an Ly2 T  transducer (acceptor) 
cell for biological activity. The need for this cell can be overcome by the addition 
of an I-J + material from Lyl + cells; and (b) the I-J + material, secreted by cells 
immunized to SRBC, shows no antigen specificity in that it can work with either 
TNP- or OX-specific TsF to overcome the need for Ly2  + cells in the immune 
population. 
The Combination of TNBSA-F and I-J  + Material Forms a Suppressive Complex That 
Is Antigen  Nonspecific.  The fact that two subfactors (TNBSA- and PCI-F) can be 
added together to form a complete suppressor factor allowed us to investigate 
whether either  subfactor alone  could  interact  with  the  I-J  +  material  to  give 
suppressive activity (Table III). While none of the subfactors alone exhibited any 
suppressive activity, mixture of TNBSA-F with  I-J + material significantly sup- 
pressed the ability of PCI  immune cells to passively transfer the CS  reaction. 
However, the suppressive activity of the TNBSA-F I-J + suppressor complex was 
no longer antigen specific in that it could equally suppress the passive transfer 
of CS to OX (group 6).  Likewise, the OX equivalent of TNBSA-F (OX-Th-F) 
formed a suppressor complex with the I-J + material that could inhibit the transfer 
of CS to either PCI or OX (group 8).  In contrast, mixtures of the I-J + material 
with the PC1-F subfactor were completely ineffective in suppressing PCl-immune 
Lyl ÷ cells (group 4). 
The Inability  to Suppress  the Passive  Transfer  of CS in  Cells Depleted of Ly2 Cells 
Can Be Overcome by Addition  of an I-J  + Molecule Induced from Antigen-primed  Ly2 I- 
J+ Cells by PCl-F.  We postulated that since the combination of TNBSA-F and I- 
J+  material  forms a  nonspecific suppressor complex that suppresses  Ly2 cell- 
TABLE  Ili 
The I-J  +  Subfactor and the TNBSA-F (or its OX Equivalent) Form an Antigen Nonspecific 
Suppressor Factor 
Group 
Source of TsF incu- 
bated with Lyl  im- 
mune cells 
CS response in adoptive recipients  ! 
PCI  OX 
1  None  6.3 --- 1.23  6.5 _  1.02 
2  I-J  K*  6.4 --+- 0.59  7.2 _  1.56 
3  PC1-F  ~  6.4 --+ 0.75  ND  ~ 
4  PCI-F +  I-J  K  5.7 ±  1.75 (93)  ND 
5  TNBSA-F  !  5.9 ±  0.75  5.9 _  125 
6  TNBSA-F +  1-J  K  2.9--- 1.45 (46, p <  0.01)  2.6 _+ 0.77 (40, p <  0:01) 
7  OX-Th-F  ~  6.1  ±  0.87  6.5 ±  0.94 
8  OX-Th-F +  l-J  K  2.2 +  0.68 (40, p <  0.01)  1.7 ±  0.80 (26, p <  0.01) 
* The I-J+ material was obtained from CBA/J SRBC-specific Lyl  TsiF by absorption of Lyl  TsiF 
with SRBC. 
* See footnote *, Table I. 
IThe  48-h  supernatants  from  cultures  of cells  from  mice  immunized  intravenously  with  either 
TNBSA  or  mouse  thymocytes (Th)  conjugated  with  OX  on  days  0  and  4  before  harvesting for 
culture on day 8. 
! See footnote 1, Table I. Numbers in parentheses are the percent of control response. 
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depleted T  cells,  the  function  of PCI-F was to induce this  I-J  + material  in  the 
assay population. We tested this in an intermediate culture system by incubating 
PCI-F,  TNP-labeled  spleen  cells,  and  T  cells  from  animals  skin  painted  with 
oxazolone for  1 h,  washing,  incubating an additional  3  h,  and asking whether 
this supernatant,  when added to TNBSA-F, could form an antigen  nonspecific 
suppressor complex that could suppress the ability of immune Ly 1 cells to transfer 
CS. The results in Table IV show that TNBSA-F plus PCI-F induced supernatant 
(PC1-Fs) were able to suppress the adoptive transfer of CS to PC1 in cells depleted 
of Ly2  + cells (line 4).  This suppressive complex was antigen-nonspecific  in that 
it could suppress the transfer of CS to both PC! and OX (groups 4 and  12). We 
also found this  factor to bear  I-J  k determinants  by passage of the  supernatant 
over anti-I-J immunosorbent columns (groups 5-8). 
We then investigated the nature of the cell producing this factor by pretreat- 
ment of immune cells with various antisera before culture. The results in Table 
V show that while supernatant from PC1-F-induced cells worked quite well with 
TNBSA-F to suppress the ability of Lyl cells to transfer CS to OX, removal of 
Ly2  + or I-J  + cells from these intermediate culture cells removes this activity. In 
contrast, treatment of immune cells with anti-Lyl  sera did not affect the ability 
of these cells to generate this I-J  + material. These results indicate that Ly2  + and 
I-J  + cells are required for the generation of this relevant I-J  + material. 
The Combination  of TNBSA-F and I-J  + Material Can Suppress the PFC Response of 
Immune Lyl + + Normal B Cells to SRBC.  We then tested the ability of the TNBSA- 
TABLE  IV 
PCI-F Can Induce an I-J  + Subfactor from Antigen-primed  T Cells That Can Work in 
Combination with TNBSA-F to Form an Antigen Nonspecific Suppressor Factor That Can 
Directly Suppress Immune Lyl T Cells in the Transfer of CS 
Lyl Cells 
immu-  Source of factor incubated  CS response  % Control 
Group  nized  with Lyl immune cells  in adoptive  response  Suppression 
with  recipients 
1  PCI  None  7.3 __+ 0.6  Standard  Standard 
2  PCI  TNBSA-F*  7.2 _+ 0.4  99  -- 
3  PCI  PCI-Fs*  7.0 _+  1.1  96  -- 
4  PCI  TNBSA-F +  PC1-Fs  1.1  _  0.9  15  +  (p <  0.001) 
5  PCI  TNBSA-F +  PCI-F~ I-J  ~-t  5.5 __. 0.6  75  -  (p >  0.1) 
6  PCI  TNBSA-F +  PCI-F~ I-J  K+  0.9 +  1.2  12  +  (p <  0.001) 
7  PCI  TNBSA-F +  PCI-FsI-J  b-I  1.4 +  0.6  19  +  (p <  0.001) 
8  PCI  TNBSA-F +  PCI-F~I-J b+  8.1  _+  1.2  >100  -- 
9  OX  None  8.1  +  0.7  Standard  Standard 
10  OX  TNBSA-F  7.3 +  0.8  90  -- 
11  OX  PCI-Fs  7.8 -  0.7  96  -- 
12  OX  TNBSA-F +  PCI-F~  1.3  --- 0.8  16  +  (p <  0.001) 
* See footnote J, Table I. 
* PC1-F, was supernatant prepared from cultures of antigen-primed T  cells, TNP-labeled spleen ceils 
and PCI-F as described in Materials and Methods. PCI-F, was added at a final dilution of 50%. 
i l_j K-  supernatant  was  filtrate  from  an  anti-I-J  K (ASM  19)  immunosorbent column  while  I-J  K+ 
supernatant was eluted material from this column. 
I  b  b  I-J - is filtrate ofsupernatant passed over an anti-l-J  (ASM 20) immunosorbent while I-J  b+ is eluate 
from this column. PCI-F~ was added to culture at a final dilution of 50% as described. PTAK  ET  AL.  1829 
TABLE  V 
Both Ly2 ÷ and I-J  ÷ Cells Are Required for the Induction of the I-j + Subfactor  Required for 
TNBSA-F Suppressive  Activity 
Treatment 
Ly 1 cells  Source of factor in-  of cells be-  CS re- 
lmmu-  sponse in  % Control 
Group  nized  cubated with Ly 1  fore induc-  adoptive  response  Suppression 
immune cells  tion by  .  . 
with  PCI-F  reoplents 
1  OX  --  0*  6.7 +  1.8  Standard  Standard 
2  OX  TNBSA-F  0  6.7 4- 1.8  100  -- 
3  OX  TNBSA-F +  PCI-F  0  6.8 4- 2.0  >100  -- 
4  OX  TNBSA-F  None  0.9 4- 1.3  13  +  (p <  0.001) 
5  OX  TNBSA-F  Anti-Lyl*  1.2 4- 1.7  18  +  (p <  0.01) 
6  OX  TNBSA-F  Anti-Ly2  6.9 4- 1.6  >100  -- 
7  OX  TNBSA-F  Anti-I-J  K  5.4 +  0.6  81  -- 
* No PCI-F induced supernatant was added. 
* Cells were treated with anti-Ly 1, anti-Ly2, or anti-I-J  K serum as described in methods before being 
added to intermediate cultures. 
TABLE  VI 
Mixtures of t-J  + Material and TNBSA-F Suppresses the Anti-SRBC PFC Response of lmmune 
Lyl T  Cells In Vitro 
I-j mate-  PFC/  % Control 
Group  Cells added to cul-  TsF added*  rial  culture  response  I  Suppression 
no.  tures *  added 
EX I 
1  Immune Lyl  T  +  B  --  --  3,300  Standard  Standard 
2  *  PCI-F  --  3,000  91  -- 
3  ~  TNBSA-F  --  3,700  >100  -- 
4  "  --  Lyl O  3,600  >100  -- 
5  ~  PCI-F  Lyl  3,100  93  -- 
6  "  TNBSA-F  Lyl  1,200  26  +  (p <  0.01) 
EX H 
7  Immune Lyl T  +  B  --  --  2,600  Standard  Standard 
8  '  PCI-F  --  2,200  85  -- 
9  '  TNBSA-F  --  2,200  85  -- 
10  '  --  Ly21  2,200  85  -- 
11  '  PCI-F  Ly2  1,900  73  -- 
12  '  TNBSA-F  Ly2  950  36  +  (p <  0.01) 
* T  cells from CBA/J mice immunized with 0.2 ml of a  1% (vol/vol) solution of SRBC  1 wk earlier 
were  treated  with anti-Ly2  and  complement and  2  ×  106  cells were  added  to  2  ×  106  Thy-1 
depleted (B) cells and SRBC. PFC responses were measured on day 5. 
* See footnote *, Table I. Factors were added at a  final concentration of 25%. 
a See footnote *, Table II. I-J  K material was added at a final concentration of 25%. 
! Ly2 I-J  + material was induced in culture by PCI-F as described in methods. I-J  k material was added 
at a final concentration of 25%. 
I Given by the formula: (experimental)/(positive control) ×  100. 
F-1-J  +  chain  complex  to  suppress  the  in  vitro  response  of  immune  Lyl ÷  cells  to 
SRBC  (Table  VI).  Lyl ÷  T  cells from  SRBC-primed  animals  were  added  to naive 
Thy-l-depleted  spleen  cells and  T  cell  factors  on  day  0  and  PFC  response  was 
measured  on  day  5.  While  none  of the  subfactors  tested  by itself were  capable  of 
suppressing  the  activity  of  Lyl  immune  cells, the  mixture  of TNBSA-F  and  1-J  + 1830  MECHANISMS OF  SUPPRESSION 
TABLE VII 
I-J  + Material Binds to TNBSA-F 
Group  Source of TsF incubated with Lyl  CS response  % Control re-  Suppression 
immune cells*  in adoptive re-  sponse 
cipients  0 
EX I 
1  None  7.5 _+ 2.0  Standard  Standard 
2  TNBSA-F  7.1  _+  1.7  95  -- 
3  Lyl-l-J  ~  7.6 +  0.6  >100  -- 
4  TNBSA-F +  Lyl-I-J  k  2.0 +  0.4  27  +  (p <  0.05) 
5  TNBSA-F ÷  Lyl-I-J  ~ filtrate*  7.1  _  0.9  95  -- 
6  TNBSA-F +  Lyl-l-J  k eluate*  2.2 -  0.4  29  +  (p <  0.05) 
EX H 
7  None  5.8 +  1.6  Standard  Standard 
8  TNBSA-F  5.3 +  0.8  91  -- 
9  Ly2-I-J  K  5.5 +  0.8  95  -- 
10  TNBSA-F +  Ly2-I-J  K  0.7 __+  1.1  12  +  (p <  0.05) 
11  TNBSA-F +  Ly2-I-J  K filtrate*  4.0 ___ 0.5  69  -- 
12  TNBSA-F +  Ly2-I-J  K eluate*  0.6 +  0.9  10  +  (p <  0.05) 
* Immune cells  of mice sensitized  to  oxazolone were  incubated  with  TNBSA-F,  I-J  k material,  or 
mixtures of both, then injected into normal recipients. 
* I-J  k material was passed over a  TNBSA-F-Sepharose 4B column and filtrate or eluate  was tested 
for its ability to give a suppressive activity to TNBSA-F. 
See footnote l, Table I. 
chain from either Lyl  ÷ or Ly2  + cells,  significantly reduced the PFC response to 
SRBC.  Mixtures of PCI-F and  I-J + chain were again completely ineffective in 
inducing suppression of immune Lyl  ÷ T  cells. 
The I-J ÷ Material that Forms a Nonspecific Suppressor Complex with TNBSA-F Binds 
to  TNBSA-F.  Since TNBSA-F and the I-J + material both from Lyl  ÷ and Ly2  + 
cells work in tandem to form a suppressive complex, we asked whether TNBSA- 
F and these  I-J  + chains show any physical association. To do this, we made a 
TNBSA-F column and passed the I-J  ÷ material through it. The activity of the 
column  filtrate and  eluate  were  assayed for  their  ability to  complement  the 
TNBSA-F to  form a  suppressor  factor that suppressed  the  transfer of CS  to 
oxazolone by immune spleen cells depleted of Ly2  + T  cells. The results in Table 
VII show that the filtrates from the column were no longer able  to generate 
suppressive activity when mixed with TNBSA-F (groups 5 and 11). In contrast, 
eluates from the same column were as effective as unseparated I-J  ÷ material in 
generating suppression when mixed with TNBSA-F (groups 6 and 12). Thus, I- 
J+ material from both Lyl  + and Ly2  + cells  shows a  strong physical association 
with TNBSA-F. 
Conclusion 
We have extensively studied (7-9) a previously described (17) antigen-specific 
T  cell factor that can suppress the transfer of delayed type hypersensitivity to 
PCI. What we found was a factor made up of two molecules (subfactors) secreted 
by  cells that express distinct cell surface phenotypes and that are activated to 
secrete  these  factors by  two  different immunization regiments (9).  The  first 
subfactor, PC1-F, is the product of an Lyl+,2  -  I-J- cell that is activated in mice PTAK  ET  AL.  1831 
by skin painting  with  PCI, an standard  way of generating  CS to PCI (13).  The 
second, TNBSA-F, is the product of an  Lyl-2  + I-j- T  cell that  is activated by 
intravenous  injection  of  trinitrobenzene  sulfonic  acid  (TNBSA),  which  is  a 
standard  way of generating  tolerance to PC1 (18).  Both of these molecules are 
required for standard suppressive activity and, while only the PCI°F has demon- 
strable antigen-binding capacity, both appear to be antigen-specific (9). 
The  mechanism  by which  these  two  molecules  effect suppression  is  by  no 
means  clear.  Previous  investigators  (10,  11,  19)  have  shown  the  need  for 
additional  T  cells in  the  assay culture  that  are  not  in  the  final  targets  of the 
suppressive activity. Sy et al. (19) report an antigen-primed T  auxiliary cell (Ts- 
aux) required for the activity of efferent T  suppressor cells. This cell is I-J  + and 
cyclophosphamide  sensitive.  Zembala  et  al.  (11)  also  report  the  need  for  an 
auxiliary cell, which they call T  acceptor cell (Tacc), for the action of TsF. This 
cell is also I-J  +, cyclophosphamide sensitive, and exhibits an Lyl-2  + phenotype. 
Our results are consistent with these given above, since we also find a need for 
an Ly2  ÷ cell in the immune populations to effect suppression.  In all likelihood, 
the three cells described here are identical. Zembala also reports that interaction 
of TsF with Tacc results in the generation of an I-J  ÷ antigen-nonspecific inhibitor 
of the  transfer  of contact sensitivity (Zembala,  personal  communication).  This 
interaction  required the presentation  of antigen on haptenated spleen cells that 
were I-J matched  with  the cells that  produced the  TsF  (10).  It appears,  then, 
that TsF-mediated suppression involves both an antigen-specific and an antigen- 
nonspecific T  cell factor, the latter being the final effector of suppression. 
We initially investigated this antigen-nonspecific phase of suppression using a 
novel approach.  Our earlier results with  Ly2 TsF, a  T  suppressor factor made 
by I-J-Ly2  + T  cells, indicated that Ly2 TsF requires an I-J  + transducer T  cell to 
effect suppressor function, the need for this transducer cell could be overcome 
by addition of an antigen-nonspecific  I-J  ÷ molecule secreted by immune T  cells 
(4).  We therefore  asked  the  question:  "Could  the  need  for  Ttrans  cell  in  the 
suppression of CS to PC! be overcome by the addition of this antigen-nonspecific 
I-J  + molecule from SRBC immune T  cells?" Our finding was that the requirement 
for  Ly2  ÷  Ttrans  cells  in  the  immune  population  could  be  alleviated  by  the 
addition of this  I-J  + molecule, and the resultant suppressive activity showed no 
antigen specificity. Our ability to look at the subfactors that make up a functional 
TsF led us to discover that the I-J  + molecule works only with one of the subfactors, 
the  TNBSA-F.  Earlier  reports  by Zembala  (10)  have  shown  that  the antigen- 
binding molecule of TsF was necessary for the induction of this antigen nonspe- 
cific I-J÷ inhibitor of CS, but found no evidence for its participation in subsequent 
suppressor activity.  We have  now shown  that  PCI-F alone  can  induce  an  I-J  + 
molecule, which can then act in tandem with the TNBSA-F to effect suppression. 
This  molecular  complex of TNBSA-F and  I-J  ÷ chain  suppresses not only the 
passive transfer of DTH, but also the ability of immune Lyl cells to stimulate B 
cells into  becoming PFC.  It appears  likely that  the antigen-nonspecific  factors 
reported earlier may be identical to our suppressor complex of I-J  + material and 
TNBSA-F. 
From  these data,  a  general  working model can be put forth  to explain  how 
these biologically active T  cell-derived factors may work (Fig.  1). Skin painting 1832  MECHANISMS  OF  SUPPRESSION 
SRBC 
Injection 
1 
I'JK~ 
I"  I-J K 
I 
CBAIJ  PCI Skin  Sensitize 
¢ 
PCI-F 
~S /~ /~  (Aq Specific) 
)T N  P  - Spleen 
TNBSA 
, Induction  I.~L  Injection 
?  -r_jK  ~' 
~  Immune  L(L~ 
I  I 
I-O K  TNBSA-F 
®  I 
C Ag Nonspecific 
DTH Effector 
or SRBC T helper 
FIGURE  1.  Proposed  mechanism of action of suppressor factors in the transfer of contact 
sensitivity (see Discussion). 
an animal with a  contact sensitizer such as PCI activates a  population of LylT 
cells that secrete an antigen-specific T  cell  factor,  PCI-F.  PCI-F then interacts 
with a population of TNP-labeled spleen cells, which in turn activates an antigen- 
primed Ly2  ÷ I-J  + cell to secrete an antigen-nonspecific I-J  + subfactor. The exact 
mechanisms by which these interactions take place are currently under investi- 
gation, but the fact that the antigen used to prime the cellular source of this I-J  + 
material is not important suggests that antigen priming serves only to clonally 
expand the population of Ly2  + T  cells that serve as a  source of these antigen- 
nonspecific I-J  + subfactors. This I-J  + chain can then complement the TNBSA-F 
either  directly (group  1)  or  by  activating an  Lyl  I-J  + cell  similar  to  the  one 
activated by hyperimmunization with SRBC (group 2). Finally, these I-J  + subfac- 
tors then combine with TNBSA-F to form a functional suppressor complex that 
can suppress immune Lyl T  cells. Although these factors do not bind antigen 
with a  measurable avidity, TNBSA-F does bind to the I-J  + molecule with which 
it cooperates in effecting suppression. This suggests that a physical association is 
required  between  the  two  molecular  entities  in  order  to  form  a  suppressive 
molecular  complex.  It  is  not  presently  known  what  the  molecular  basis  for 
interchain bonding is or whether there is any genetic restrictions in the ability 
of these factors to interact with one another.  Preliminary results suggest, how- 
ever, that there is a genetic restriction in the ability of TNBSA-F and I-J  + chain 
to suppress. The nature of these genetic restrictions are currently being investi- 
gated. 
At present, we have no direct evidence linking the Ly2  + cell induced by PCI- 
F to secrete the I-J + molecule needed for TsF activity with the SRBC-induced PTAK  ET  AL.  1833 
Lyl ÷ T  cell source of the I-J  ÷ material that can also interact with TNBSA-F to 
form a nonspecific suppressor molecule. However, there are a number of striking 
similarities in the activation phase of both cell types: (a) both require the presence 
of the  antigen-specific portion  of TsF  to  be  activated;  (b)  both  require  the 
presence of antigen and antigen presenting cells during activation; and (c) both 
combine with an Ly2  + T  cell product to effect suppression. 2 Therefore, it seems 
likely that the Lyl ÷ I-J  ÷ cell in the SRBC  system is playing a  physiologic role 
very similar to  the one played by the Ly2  ÷ Ttrans  cell in  the suppression  of 
adoptive transfer of DTH. This postulate is strengthened by the fact that secreted 
products  from  one  cell  can  replace  the  need  for  the  other  cell  to  yield  a 
functionally identical product. 
It  therefore appears  that  the  biological  activity of soluble  products  in  the 
suppression of DTH depends upon the interaction of a  number of T  cell sets. 
The  exact  nature of these  interactions  is  as  yet unknown,  but  the  evidence 
suggests the participation  of at  least three independent macromolecules. The 
fact that subfactors raised against SRBC can aid TNBSA-F in suppressing DTH 
responses, and  vice versa,  suggests a  universality in  the mechanism by which 
suppressor cells find and suppress their target cells. A second important point is 
that, in these experiments, the molecule that suppresses has no antigen-specific 
receptor on it, and at the same time shows no antigen-specific suppressor activity. 
However, in  factors  that  exhibit an  antigen-binding receptor,  the suppressor 
molecule will only work on cells with which it can form an antigen bridge.  In 
considering any antigen-nonspecific factor, it must be asked whether it is, in fact, 
a  component of an antigen-specific complex. The loss of that antigen-specific 
portion of the molecule may result in a molecular complex that is then antigen- 
nonspecific but functions by utilizing an antigen-specific molecule supplied by 
the  assay  population.  Immune  Lyl ÷ T  cells  spontaneously  produce antigen- 
specific regulatory molecules (3, 9).  The use of T  cell subfactors to dissect the 
molecular interactions necessary to deliver the suppressive signal will help us in 
analyzing these complexities of immunoregulation. 
Summary 
The passive transfer of contact sensitivity (CS) by immune cells can be inhibited 
with an antigen-specific T  suppressor  factor.  This  factor is  composed of two 
subfactors:  an  antigen-specific subfactor made by an  Lyl + cell  (PCI-F)  and  a 
antigen nonspecific subfactor made by an Ly2  + T  cell (TNBSA-F). The suppres- 
sive activity of the complete factor can be  eliminated by depleting the assay 
population of Ly2  + cells, even though it is the Lyl ÷ cell in the population that 
transfers the adoptive immunity. This suggests that the Ly2  + cell in the assay 
population is needed to transduce the suppressive signal to the Lyl + effector cell 
of DTH. 
We found that an Ly2  ÷ cell from immune animals could be induced to produce 
a cell free subfactor that overcame the requirement for this Ttrans cell in the 
suppression of CS by TsF.  The induction required only PC1-F, TNP-coupled 
2 Flood, P.  M., and  R.  K. Gershon.  Mechanisms of Ly2 suppressor  cell activity: analysis of the 
induction of an Lyl  I-J  + cell needed to transduce the suppressive signal. Manuscript submitted for 
publication. 1.834  MECHANISMS OF  SUPPRESSION 
spleen cells, and resulted in the production of an antigen-nonspecific I-J  + subfac- 
tor by immune Ly2  +, I-J  + cells. The need for the Ly2  + transducer cell could also 
be overcome by addition of an  I-J  + molecule secreted by Lyl T  cells hyperim- 
munized to SRBC.  A  suppressor complex made from mixing the I-J  + molecule 
with TNBSA-F could directly suppress the functional activity of immune T  cells 
not 0nly to transfer CS,  but also to deliver help to B  cells in an  in  vitro PFC 
response. This suppressive complex is antigen-nonspecific and does not require 
Ly2  ÷ T  cells in the assay population for suppressive activity. 
These results  indicate  that  effector factors of the  suppressor circuit require 
two molecules; one that contains the functional suppressor material and one that 
serves  as  a  "schlepper,"  a  molecule  needed  to  deliver  the  suppression  to  the 
appropriate target cell. The ability to construct a  functional suppressor complex 
from two subfactors raised against different antigens, using different immuniza- 
tion procedures, which were isolated from factors exhibiting different functional 
activities suggests that certain cells of the immune system may play a  universal 
role in "transducing" the suppressive signal. 
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